Search

everythinglearnresearchcommunity

for

Search:↓

Ginger may help reduce testosterone and improve menstrual issues in women with PCOS.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

In PCOS, high male hormones cause hair growth, acne, and hair loss, affecting periods.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Women with excessive body hair often have higher male hormones and related health issues.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Perforin and granzyme-B may influence hormone levels in women with PCOS.

Early-onset hair loss in Egyptian males is linked to genetics, hormones, and lifestyle factors like smoking and diet.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.